P/B
—
Nuwellis
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
$2.8M
Market Cap • 9/25/2026
2002
(24 years)
Founded
2012
(14 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
0,3
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
—
EPS
—
Market Cap
Market Cap
2,8M
EV
-882,5K
EV/Revenue
-0,1
EV/EBITDA
0,1
EV/EBIT
0,1
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-436,8%
Total Yield
-436,8%
Payout
0%
Retained Earnings
-325,7M
Profitability
Gross Margin
69,7%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
1,4%
Capex/D&A
82,2%
Capex/OCF
-1%
SBC/OCF
—
% PPE
5,8%
% Goodwill
0%
ROE
205,9%
ROIC
—
Growth
CAGR Revenue 5Y
1,5%
CAGR Op. Income 5Y
-7%
CAGR Net Income 5Y
-8,1%
CAGR OCF 5Y
-6%
Leverage
N.D./EBITDA
0,3
Debt/Equity
0%
Current Ratio
2
Quick Ratio
1,4
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!